Diabetes Mellitus, Type 2NCT06986876
Exploration of the Perceptions of Women With a History of Gestational Diabetes From the Gonesse Hospital Catchment Area Regarding Their Risk of Developing Type 2 Diabetes.
An observational study of Diabetes Mellitus, Type 2 and Diabetes, Gestational, run by Centre Hospitalier de Gonesse at 1 site in France.
Trial summary
This study focuses on the patients' perspective and aims to provide explanatory elements regarding the barriers to type 2 diabetes screening among women with a history of gestational diabetes. Read more about this study
- Who is it for?
- Ages 18 to 45 years, women only
- Conditions the study is for
- Diabetes Mellitus, Type 2, Diabetes, Gestational
- How many people
- 12 participants
- Where
- 1 siteFrance
- Study dates
- 15 Jan 2025to 15 May 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- Women only
- Adult
Study population: The study population will consist of women aged 18 to 45 years who have a history of gestational diabetes, are French-speaking, and reside within the catchment area of Gonesse Hospital (Île-de-France region, France). These participants represent a population at increased risk of developing type 2 diabetes and are targeted for better understanding of the barriers and facilitators to post-partum diabetes screening.
Who may be able to join
- Women with a history of gestational diabetes
- Aged between 18 and 45 years
- French-speaking
- Followed up at Gonesse Hospital
Who cannot join
- Under 18 or over 45 years old
- Non-French-speaking
Trial locations and contacts
1 site in 1 country.
About this study
This study focuses on the patients' perspective and aims to provide explanatory elements regarding the barriers to type 2 diabetes screening among women with a history of gestational diabetes. The main objective is to understand the obstacles and enablers in order to optimize type 2 diabetes screening in women with a history of gestational diabetes.
- Conditions
- Diabetes Mellitus, Type 2, Diabetes, Gestational
- Medical subject headings
- Diabetes Mellitus, Type 2, Diabetes, Gestational
What is being measured
The primary outcome is the main question the study is designed to answer.
Identification and qualitative analysis of the factors influencing participation in type 2 diabetes screening among women with a history of gestational diabetes.
Measured: 15 january 2025 - 15 may 2025
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 May 2025
- Study start15 Jan 2025
- Primary completion15 May 2025
- Study completion15 May 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Diabetes Mellitus, Type 2Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 12 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier de Gonesse
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06986876
- Sponsor's protocol ID
- 0093_ENDOCRINOLOGIE
- Status last verified
- May 2025
- First submitted
- 15 May 2025
- Last updated
- 23 May 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 23 May 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Exploration of the Perceptions of Women With a History of Gestational Diabetes From the Gonesse Hospital Catchment Area Regarding Their Risk of Developing Type 2 Diabetes.
- ClinicalTrials.gov ID
- NCT06986876
- Acronym / sponsor ID
- 0093_ENDOCRINOLOGIE
- Conditions
- Diabetes Mellitus, Type 2, Diabetes, Gestational
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 12 participants (actual)
- Lead sponsor
- Centre Hospitalier de GonesseUniversity, hospital or other
- Study start
- 15 Jan 2025 (actual)
- Primary completion
- 15 May 2025 (actual)
- Study completion
- 15 May 2025 (actual)
- First posted
- 23 May 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study focuses on the patients' perspective and aims to provide explanatory elements regarding the barriers to type 2 diabetes screening among women with a history of gestational diabetes. The main objective is to understand the obstacles and enablers in order to optimize type 2 diabetes screening in women with a history of gestational diabetes.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 45 years
- Sex
- Female only
- Age groups
- Adult
- Study population
- The study population will consist of women aged 18 to 45 years who have a history of gestational diabetes, are French-speaking, and reside within the catchment area of Gonesse Hospital (Île-de-France region, France). These participants represent a population at increased risk of developing type 2 diabetes and are targeted for better understanding of the barriers and facilitators to post-partum diabetes screening.
Key inclusion criteria (4 listed)
- Women with a history of gestational diabetes
- Aged between 18 and 45 years
- French-speaking
- Followed up at Gonesse Hospital
Key exclusion criteria (2 listed)
- Under 18 or over 45 years old
- Non-French-speaking
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Identification and qualitative analysis of the factors influencing participation in type 2 diabetes screening among women with a history of gestational diabetes.
Time frame: 15 january 2025 - 15 may 2025
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 May 2025.
Related trials for Diabetes Mellitus, Type 2
Not yet recruitingPhase 3
Efficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 Diabetes
Type 2 Diabetes
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Not yet recruitingPhase 3
A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes
Obesity, Overweight
Not yet recruiting
Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)
Type 2 Diabetes Mellitus (T2D), Obesity (BMI>30)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Diabetes Mellitus, Type 2 and Diabetes, Gestational, run by Centre Hospitalier de Gonesse at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 May 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Identification and qualitative analysis of the factors influencing participation in type 2 diabetes screening among women with a history of gestational diabetes. (time frame: 15 january 2025 - 15 may 2025). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 May 2025.